Global Liver Function Tests

Liver Function Tests Comprehensive Study by Type (Alanine Aminotransferase Test, Aspartate Aminotransferase Test, Alkaline Phosphatase Test, Gamma GT Test, Total Bilirubin, Albumin, Others), Application (Disease Diagnose, Blood Routine Analysis, Disease Prevention, Others), Disease Indication (Hepatitis A) Players and Region - Global Market Outlook to 2030

Liver Function Tests Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Liver Function Tests Market Scope
Liver function tests (LFTs) also referred to as hepatic function tests, which help to determine liver health by measuring and monitoring the level of protein, liver enzymes and bilirubin present in the blood. The tests are used to detect liver disease, and also to prevent the disease beforehand, gauges the limit to what extent the liver is damaged and also monitors the response of the treatment given. The liver function tests can be done as a routine checkup, alcoholism, certain medications someone has been taking for a very long period can be the reasons to get checked.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledAlpha Laboratories Ltd. (United Kingdom), ELITechGroup (France), Abbott Laboratories (United States), Horiba Medical Ltd. (France), Laboratory Corporation of America Holdings (United States), Randox Laboratories (United Kingdom), Thermo Fisher Scientific (United States), F. Hoffmann-La Roche AG (Switzerland), Endo Pharmaceuticals Inc. (Ireland) and Novartis Consumer Health Inc. (Switzerland)
CAGR5.8%


The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market shortly. Players are anticipated to focus on the development of new compounds, which is likely to encourage the growth of the global market throughout the forecast period. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Liver Function Tests market throughout the predicted period.

Alpha Laboratories Ltd. (United Kingdom), ELITechGroup (France), Abbott Laboratories (United States), Horiba Medical Ltd. (France), Laboratory Corporation of America Holdings (United States), Randox Laboratories (United Kingdom), Thermo Fisher Scientific (United States), F. Hoffmann-La Roche AG (Switzerland), Endo Pharmaceuticals Inc. (Ireland) and Novartis Consumer Health Inc. (Switzerland) are some of the key players that are part of study coverage.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Liver Function Tests market by Type , by Application (Disease Diagnose, Blood Routine Analysis, Disease Prevention and Others) and Region with country level break-up.

On the basis of geography, the market of Liver Function Tests has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies


"The Food and Drug Administration said that the manufacturers—Endo Pharmaceuticals Inc., and Novartis Consumer Health Inc.—had revised the “hepatic effects” section of the diclofenac topical gel label to include new warnings and precautions about the potential for elevated liver function tests (LFTs) during treatment. The revised label both recommend that clinicians should periodically measure transaminase levels in patients taking diclofenac long-term. While the optimum schedule for checking transaminase levels is unknown, clinical trial data and postmarketing experience indicate that levels should be monitored within 4–8 weeks after initiating treatment, according to the FDA notice."

Influencing Trend:
Liver Disease and its Function Tests are more Prevalent in Pregnant Women and Prevalence of ALT/AST For Diagnosing Liver Related Diseases

Market Growth Drivers:
Increasing Geriatric Population Around the Globe and Rising Consumption of Alcohol is Increasing Liver Function Tests

Challenges:
High Cost Involved in the Liver Function Tests

Restraints:
Difficulties in Determining the Type of Disease and Possible Causes

Opportunities:
Raising Awareness about the Liver Diseases will Boost the Liver Function Tests Market and Technological Advancements in Liver Test Equipments and Diagnosis

Key Target Audience
Liver Function Tests Providers, Liver Function Tests Equipment Manufacturers, Research and Development Institutes, National Laboratories, Regulatory Bodies, Hospitals, Potential Investors and Others

Report Objectives / Segmentation Covered

By Type
  • Alanine Aminotransferase Test
  • Aspartate Aminotransferase Test
  • Alkaline Phosphatase Test
  • Gamma GT Test
  • Total Bilirubin
  • Albumin
  • Others
By Application
  • Disease Diagnose
  • Blood Routine Analysis
  • Disease Prevention
  • Others
By Disease Indication
  • Hepatitis A

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Geriatric Population Around the Globe
      • 3.2.2. Rising Consumption of Alcohol is Increasing Liver Function Tests
    • 3.3. Market Challenges
      • 3.3.1. High Cost Involved in the Liver Function Tests
    • 3.4. Market Trends
      • 3.4.1. Liver Disease and its Function Tests are more Prevalent in Pregnant Women
      • 3.4.2. Prevalence of ALT/AST For Diagnosing Liver Related Diseases
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Liver Function Tests, by Type, Application, Disease Indication and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Liver Function Tests (Value)
      • 5.2.1. Global Liver Function Tests by: Type (Value)
        • 5.2.1.1. Alanine Aminotransferase Test
        • 5.2.1.2. Aspartate Aminotransferase Test
        • 5.2.1.3. Alkaline Phosphatase Test
        • 5.2.1.4. Gamma GT Test
        • 5.2.1.5. Total Bilirubin
        • 5.2.1.6. Albumin
        • 5.2.1.7. Others
      • 5.2.2. Global Liver Function Tests by: Application (Value)
        • 5.2.2.1. Disease Diagnose
        • 5.2.2.2. Blood Routine Analysis
        • 5.2.2.3. Disease Prevention
        • 5.2.2.4. Others
      • 5.2.3. Global Liver Function Tests by: Disease Indication (Value)
        • 5.2.3.1. Hepatitis A
      • 5.2.4. Global Liver Function Tests Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Liver Function Tests: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alpha Laboratories Ltd. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ELITechGroup (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Horiba Medical Ltd. (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Laboratory Corporation of America Holdings (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Randox Laboratories (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Thermo Fisher Scientific (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Endo Pharmaceuticals Inc. (Ireland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Novartis Consumer Health Inc. (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Liver Function Tests Sale, by Type, Application, Disease Indication and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Liver Function Tests (Value)
      • 7.2.1. Global Liver Function Tests by: Type (Value)
        • 7.2.1.1. Alanine Aminotransferase Test
        • 7.2.1.2. Aspartate Aminotransferase Test
        • 7.2.1.3. Alkaline Phosphatase Test
        • 7.2.1.4. Gamma GT Test
        • 7.2.1.5. Total Bilirubin
        • 7.2.1.6. Albumin
        • 7.2.1.7. Others
      • 7.2.2. Global Liver Function Tests by: Application (Value)
        • 7.2.2.1. Disease Diagnose
        • 7.2.2.2. Blood Routine Analysis
        • 7.2.2.3. Disease Prevention
        • 7.2.2.4. Others
      • 7.2.3. Global Liver Function Tests by: Disease Indication (Value)
        • 7.2.3.1. Hepatitis A
      • 7.2.4. Global Liver Function Tests Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Liver Function Tests: by Type(USD Million)
  • Table 2. Liver Function Tests Alanine Aminotransferase Test , by Region USD Million (2018-2023)
  • Table 3. Liver Function Tests Aspartate Aminotransferase Test , by Region USD Million (2018-2023)
  • Table 4. Liver Function Tests Alkaline Phosphatase Test , by Region USD Million (2018-2023)
  • Table 5. Liver Function Tests Gamma GT Test , by Region USD Million (2018-2023)
  • Table 6. Liver Function Tests Total Bilirubin , by Region USD Million (2018-2023)
  • Table 7. Liver Function Tests Albumin , by Region USD Million (2018-2023)
  • Table 8. Liver Function Tests Others , by Region USD Million (2018-2023)
  • Table 9. Liver Function Tests: by Application(USD Million)
  • Table 10. Liver Function Tests Disease Diagnose , by Region USD Million (2018-2023)
  • Table 11. Liver Function Tests Blood Routine Analysis , by Region USD Million (2018-2023)
  • Table 12. Liver Function Tests Disease Prevention , by Region USD Million (2018-2023)
  • Table 13. Liver Function Tests Others , by Region USD Million (2018-2023)
  • Table 14. Liver Function Tests: by Disease Indication(USD Million)
  • Table 15. Liver Function Tests Hepatitis A , by Region USD Million (2018-2023)
  • Table 16. South America Liver Function Tests, by Country USD Million (2018-2023)
  • Table 17. South America Liver Function Tests, by Type USD Million (2018-2023)
  • Table 18. South America Liver Function Tests, by Application USD Million (2018-2023)
  • Table 19. South America Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 20. Brazil Liver Function Tests, by Type USD Million (2018-2023)
  • Table 21. Brazil Liver Function Tests, by Application USD Million (2018-2023)
  • Table 22. Brazil Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 23. Argentina Liver Function Tests, by Type USD Million (2018-2023)
  • Table 24. Argentina Liver Function Tests, by Application USD Million (2018-2023)
  • Table 25. Argentina Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 26. Rest of South America Liver Function Tests, by Type USD Million (2018-2023)
  • Table 27. Rest of South America Liver Function Tests, by Application USD Million (2018-2023)
  • Table 28. Rest of South America Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 29. Asia Pacific Liver Function Tests, by Country USD Million (2018-2023)
  • Table 30. Asia Pacific Liver Function Tests, by Type USD Million (2018-2023)
  • Table 31. Asia Pacific Liver Function Tests, by Application USD Million (2018-2023)
  • Table 32. Asia Pacific Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 33. China Liver Function Tests, by Type USD Million (2018-2023)
  • Table 34. China Liver Function Tests, by Application USD Million (2018-2023)
  • Table 35. China Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 36. Japan Liver Function Tests, by Type USD Million (2018-2023)
  • Table 37. Japan Liver Function Tests, by Application USD Million (2018-2023)
  • Table 38. Japan Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 39. India Liver Function Tests, by Type USD Million (2018-2023)
  • Table 40. India Liver Function Tests, by Application USD Million (2018-2023)
  • Table 41. India Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 42. South Korea Liver Function Tests, by Type USD Million (2018-2023)
  • Table 43. South Korea Liver Function Tests, by Application USD Million (2018-2023)
  • Table 44. South Korea Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 45. Taiwan Liver Function Tests, by Type USD Million (2018-2023)
  • Table 46. Taiwan Liver Function Tests, by Application USD Million (2018-2023)
  • Table 47. Taiwan Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 48. Australia Liver Function Tests, by Type USD Million (2018-2023)
  • Table 49. Australia Liver Function Tests, by Application USD Million (2018-2023)
  • Table 50. Australia Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Liver Function Tests, by Type USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Liver Function Tests, by Application USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 54. Europe Liver Function Tests, by Country USD Million (2018-2023)
  • Table 55. Europe Liver Function Tests, by Type USD Million (2018-2023)
  • Table 56. Europe Liver Function Tests, by Application USD Million (2018-2023)
  • Table 57. Europe Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 58. Germany Liver Function Tests, by Type USD Million (2018-2023)
  • Table 59. Germany Liver Function Tests, by Application USD Million (2018-2023)
  • Table 60. Germany Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 61. France Liver Function Tests, by Type USD Million (2018-2023)
  • Table 62. France Liver Function Tests, by Application USD Million (2018-2023)
  • Table 63. France Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 64. Italy Liver Function Tests, by Type USD Million (2018-2023)
  • Table 65. Italy Liver Function Tests, by Application USD Million (2018-2023)
  • Table 66. Italy Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 67. United Kingdom Liver Function Tests, by Type USD Million (2018-2023)
  • Table 68. United Kingdom Liver Function Tests, by Application USD Million (2018-2023)
  • Table 69. United Kingdom Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 70. Netherlands Liver Function Tests, by Type USD Million (2018-2023)
  • Table 71. Netherlands Liver Function Tests, by Application USD Million (2018-2023)
  • Table 72. Netherlands Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 73. Rest of Europe Liver Function Tests, by Type USD Million (2018-2023)
  • Table 74. Rest of Europe Liver Function Tests, by Application USD Million (2018-2023)
  • Table 75. Rest of Europe Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 76. MEA Liver Function Tests, by Country USD Million (2018-2023)
  • Table 77. MEA Liver Function Tests, by Type USD Million (2018-2023)
  • Table 78. MEA Liver Function Tests, by Application USD Million (2018-2023)
  • Table 79. MEA Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 80. Middle East Liver Function Tests, by Type USD Million (2018-2023)
  • Table 81. Middle East Liver Function Tests, by Application USD Million (2018-2023)
  • Table 82. Middle East Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 83. Africa Liver Function Tests, by Type USD Million (2018-2023)
  • Table 84. Africa Liver Function Tests, by Application USD Million (2018-2023)
  • Table 85. Africa Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 86. North America Liver Function Tests, by Country USD Million (2018-2023)
  • Table 87. North America Liver Function Tests, by Type USD Million (2018-2023)
  • Table 88. North America Liver Function Tests, by Application USD Million (2018-2023)
  • Table 89. North America Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 90. United States Liver Function Tests, by Type USD Million (2018-2023)
  • Table 91. United States Liver Function Tests, by Application USD Million (2018-2023)
  • Table 92. United States Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 93. Canada Liver Function Tests, by Type USD Million (2018-2023)
  • Table 94. Canada Liver Function Tests, by Application USD Million (2018-2023)
  • Table 95. Canada Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 96. Mexico Liver Function Tests, by Type USD Million (2018-2023)
  • Table 97. Mexico Liver Function Tests, by Application USD Million (2018-2023)
  • Table 98. Mexico Liver Function Tests, by Disease Indication USD Million (2018-2023)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Liver Function Tests: by Type(USD Million)
  • Table 110. Liver Function Tests Alanine Aminotransferase Test , by Region USD Million (2025-2030)
  • Table 111. Liver Function Tests Aspartate Aminotransferase Test , by Region USD Million (2025-2030)
  • Table 112. Liver Function Tests Alkaline Phosphatase Test , by Region USD Million (2025-2030)
  • Table 113. Liver Function Tests Gamma GT Test , by Region USD Million (2025-2030)
  • Table 114. Liver Function Tests Total Bilirubin , by Region USD Million (2025-2030)
  • Table 115. Liver Function Tests Albumin , by Region USD Million (2025-2030)
  • Table 116. Liver Function Tests Others , by Region USD Million (2025-2030)
  • Table 117. Liver Function Tests: by Application(USD Million)
  • Table 118. Liver Function Tests Disease Diagnose , by Region USD Million (2025-2030)
  • Table 119. Liver Function Tests Blood Routine Analysis , by Region USD Million (2025-2030)
  • Table 120. Liver Function Tests Disease Prevention , by Region USD Million (2025-2030)
  • Table 121. Liver Function Tests Others , by Region USD Million (2025-2030)
  • Table 122. Liver Function Tests: by Disease Indication(USD Million)
  • Table 123. Liver Function Tests Hepatitis A , by Region USD Million (2025-2030)
  • Table 124. South America Liver Function Tests, by Country USD Million (2025-2030)
  • Table 125. South America Liver Function Tests, by Type USD Million (2025-2030)
  • Table 126. South America Liver Function Tests, by Application USD Million (2025-2030)
  • Table 127. South America Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 128. Brazil Liver Function Tests, by Type USD Million (2025-2030)
  • Table 129. Brazil Liver Function Tests, by Application USD Million (2025-2030)
  • Table 130. Brazil Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 131. Argentina Liver Function Tests, by Type USD Million (2025-2030)
  • Table 132. Argentina Liver Function Tests, by Application USD Million (2025-2030)
  • Table 133. Argentina Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 134. Rest of South America Liver Function Tests, by Type USD Million (2025-2030)
  • Table 135. Rest of South America Liver Function Tests, by Application USD Million (2025-2030)
  • Table 136. Rest of South America Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 137. Asia Pacific Liver Function Tests, by Country USD Million (2025-2030)
  • Table 138. Asia Pacific Liver Function Tests, by Type USD Million (2025-2030)
  • Table 139. Asia Pacific Liver Function Tests, by Application USD Million (2025-2030)
  • Table 140. Asia Pacific Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 141. China Liver Function Tests, by Type USD Million (2025-2030)
  • Table 142. China Liver Function Tests, by Application USD Million (2025-2030)
  • Table 143. China Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 144. Japan Liver Function Tests, by Type USD Million (2025-2030)
  • Table 145. Japan Liver Function Tests, by Application USD Million (2025-2030)
  • Table 146. Japan Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 147. India Liver Function Tests, by Type USD Million (2025-2030)
  • Table 148. India Liver Function Tests, by Application USD Million (2025-2030)
  • Table 149. India Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 150. South Korea Liver Function Tests, by Type USD Million (2025-2030)
  • Table 151. South Korea Liver Function Tests, by Application USD Million (2025-2030)
  • Table 152. South Korea Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 153. Taiwan Liver Function Tests, by Type USD Million (2025-2030)
  • Table 154. Taiwan Liver Function Tests, by Application USD Million (2025-2030)
  • Table 155. Taiwan Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 156. Australia Liver Function Tests, by Type USD Million (2025-2030)
  • Table 157. Australia Liver Function Tests, by Application USD Million (2025-2030)
  • Table 158. Australia Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Liver Function Tests, by Type USD Million (2025-2030)
  • Table 160. Rest of Asia-Pacific Liver Function Tests, by Application USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 162. Europe Liver Function Tests, by Country USD Million (2025-2030)
  • Table 163. Europe Liver Function Tests, by Type USD Million (2025-2030)
  • Table 164. Europe Liver Function Tests, by Application USD Million (2025-2030)
  • Table 165. Europe Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 166. Germany Liver Function Tests, by Type USD Million (2025-2030)
  • Table 167. Germany Liver Function Tests, by Application USD Million (2025-2030)
  • Table 168. Germany Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 169. France Liver Function Tests, by Type USD Million (2025-2030)
  • Table 170. France Liver Function Tests, by Application USD Million (2025-2030)
  • Table 171. France Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 172. Italy Liver Function Tests, by Type USD Million (2025-2030)
  • Table 173. Italy Liver Function Tests, by Application USD Million (2025-2030)
  • Table 174. Italy Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 175. United Kingdom Liver Function Tests, by Type USD Million (2025-2030)
  • Table 176. United Kingdom Liver Function Tests, by Application USD Million (2025-2030)
  • Table 177. United Kingdom Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 178. Netherlands Liver Function Tests, by Type USD Million (2025-2030)
  • Table 179. Netherlands Liver Function Tests, by Application USD Million (2025-2030)
  • Table 180. Netherlands Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 181. Rest of Europe Liver Function Tests, by Type USD Million (2025-2030)
  • Table 182. Rest of Europe Liver Function Tests, by Application USD Million (2025-2030)
  • Table 183. Rest of Europe Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 184. MEA Liver Function Tests, by Country USD Million (2025-2030)
  • Table 185. MEA Liver Function Tests, by Type USD Million (2025-2030)
  • Table 186. MEA Liver Function Tests, by Application USD Million (2025-2030)
  • Table 187. MEA Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 188. Middle East Liver Function Tests, by Type USD Million (2025-2030)
  • Table 189. Middle East Liver Function Tests, by Application USD Million (2025-2030)
  • Table 190. Middle East Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 191. Africa Liver Function Tests, by Type USD Million (2025-2030)
  • Table 192. Africa Liver Function Tests, by Application USD Million (2025-2030)
  • Table 193. Africa Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 194. North America Liver Function Tests, by Country USD Million (2025-2030)
  • Table 195. North America Liver Function Tests, by Type USD Million (2025-2030)
  • Table 196. North America Liver Function Tests, by Application USD Million (2025-2030)
  • Table 197. North America Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 198. United States Liver Function Tests, by Type USD Million (2025-2030)
  • Table 199. United States Liver Function Tests, by Application USD Million (2025-2030)
  • Table 200. United States Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 201. Canada Liver Function Tests, by Type USD Million (2025-2030)
  • Table 202. Canada Liver Function Tests, by Application USD Million (2025-2030)
  • Table 203. Canada Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 204. Mexico Liver Function Tests, by Type USD Million (2025-2030)
  • Table 205. Mexico Liver Function Tests, by Application USD Million (2025-2030)
  • Table 206. Mexico Liver Function Tests, by Disease Indication USD Million (2025-2030)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Liver Function Tests: by Type USD Million (2018-2023)
  • Figure 5. Global Liver Function Tests: by Application USD Million (2018-2023)
  • Figure 6. Global Liver Function Tests: by Disease Indication USD Million (2018-2023)
  • Figure 7. South America Liver Function Tests Share (%), by Country
  • Figure 8. Asia Pacific Liver Function Tests Share (%), by Country
  • Figure 9. Europe Liver Function Tests Share (%), by Country
  • Figure 10. MEA Liver Function Tests Share (%), by Country
  • Figure 11. North America Liver Function Tests Share (%), by Country
  • Figure 12. Global Liver Function Tests share by Players 2023 (%)
  • Figure 13. Global Liver Function Tests share by Players (Top 3) 2023(%)
  • Figure 14. Global Liver Function Tests share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Alpha Laboratories Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. Alpha Laboratories Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 18. ELITechGroup (France) Revenue, Net Income and Gross profit
  • Figure 19. ELITechGroup (France) Revenue: by Geography 2023
  • Figure 20. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott Laboratories (United States) Revenue: by Geography 2023
  • Figure 22. Horiba Medical Ltd. (France) Revenue, Net Income and Gross profit
  • Figure 23. Horiba Medical Ltd. (France) Revenue: by Geography 2023
  • Figure 24. Laboratory Corporation of America Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 25. Laboratory Corporation of America Holdings (United States) Revenue: by Geography 2023
  • Figure 26. Randox Laboratories (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 27. Randox Laboratories (United Kingdom) Revenue: by Geography 2023
  • Figure 28. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 29. Thermo Fisher Scientific (United States) Revenue: by Geography 2023
  • Figure 30. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2023
  • Figure 32. Endo Pharmaceuticals Inc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 33. Endo Pharmaceuticals Inc. (Ireland) Revenue: by Geography 2023
  • Figure 34. Novartis Consumer Health Inc. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 35. Novartis Consumer Health Inc. (Switzerland) Revenue: by Geography 2023
  • Figure 36. Global Liver Function Tests: by Type USD Million (2025-2030)
  • Figure 37. Global Liver Function Tests: by Application USD Million (2025-2030)
  • Figure 38. Global Liver Function Tests: by Disease Indication USD Million (2025-2030)
  • Figure 39. South America Liver Function Tests Share (%), by Country
  • Figure 40. Asia Pacific Liver Function Tests Share (%), by Country
  • Figure 41. Europe Liver Function Tests Share (%), by Country
  • Figure 42. MEA Liver Function Tests Share (%), by Country
  • Figure 43. North America Liver Function Tests Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Alpha Laboratories Ltd. (United Kingdom)
  • ELITechGroup (France)
  • Abbott Laboratories (United States)
  • Horiba Medical Ltd. (France)
  • Laboratory Corporation of America Holdings (United States)
  • Randox Laboratories (United Kingdom)
  • Thermo Fisher Scientific (United States)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Endo Pharmaceuticals Inc. (Ireland)
  • Novartis Consumer Health Inc. (Switzerland)
Select User Access Type

Key Highlights of Report


Apr 2024 240 Pages 70 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Liver Function Tests Quantitative research analysis
Global Liver Function Tests Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Liver Function Tests Market are by type [Alanine Aminotransferase Test, Aspartate Aminotransferase Test, Alkaline Phosphatase Test, Gamma GT Test, Total Bilirubin, Albumin and Others], by end use application [Disease Diagnose, Blood Routine Analysis, Disease Prevention and Others].
The Liver Function Tests Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Geriatric Population Around the Globe
  • Rising Consumption of Alcohol is Increasing Liver Function Tests

Know More About Global Liver Function Tests Report?

Have a Query? Click Here

Other Related Reports

Male Infertility Treatment Comprehensive Study by Type (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm P...
$ 3800
Jet Lag Treatment Comprehensive Study by Type (Light therapy, Medications), Application (Hospital Pharmacies, Retail Pharmacies, Online Sales, Drug Stores), Drug (Prescription drugs, Melatonin, Her...
$ 3650
Medical Device Cleaning Comprehensive Study by Type (Automatic Cleaning, Manual Cleaning), Application (Hospital, Clinics, Others), Product Type (Enzymatic Detergents, Non-enzymatic Detergents, Alkal...
$ 3650
Animal Model Services Comprehensive Study by Type (Mice, Rats, Fish, Birds, Cattles, Others), Application (Infectious Disease, Immunological Diseases, Cancer, Cardiovascular Diseases, Diabetes, Genet...
$ 3750
Gastrointestinal Cancer Treatment Comprehensive Study by Drug Type (Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib, Trastuzumab), Therapy (Immunotherapy, Chemother...
$ 3750
Veterinary Medication Comprehensive Study by Type (Biologics, Pharmaceuticals, Medicated Feed Additives), Deployment Mode (Oral, Parenteral, Suspension, Topical, Carrier), Distribution Channel (Veter...
$ 3800